New! Make Your CRM Smarter with Best-In-Class Intent Data

Learn More!
MicroGen Diagnostics

MicroGen Diagnostics

MicroGenDX is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvements Amendments (CLIA) licensed clinical laboratory with more than 12 years of experience in diagnosing molecular-based, laboratory-developed tests. MicroGenDX operates a high-complexity diagnostic laboratory that uses Polymerase Chain Reaction (PCR) and Next Generation DNA Sequencing Technology ("NGS Technology") - rather than the traditional approach of growing cultures - to determine the presence of, and identify by their genetic markers, specific micro-organisms that are the cause of infections. MicroGenDX's technology and mission are improving and saving the lives of patients with serious and often chronic infections and diseases by using the latest science and the most precise diagnostic tool available to identify the cause of infection so that the most effective medicine can be prescribed to treat that infection. Thousands of patients with chronic and often life-threatening infections have benefited from MicroGenDX's work.

Last updated on

About MicroGen Diagnostics

Founded

2011

Estimated Revenue

$10M-$50M

Employees

51-250

Funding / Mkt. Cap

$1M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

Lubbock

State

Texas

Country

United States

Tech Stack (113)

search

Business Intelligence And Analytics

Programming Languages And Frameworks

Computer Networks

Payment

Content Management System

Verified CDN